IQVIA Holdings Inc. (IQV) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
IQVIA Holdings Inc. (IQV) slipped -1.43% to $275.06 as options desks priced 53% call premium vs. 47% put protection around the $270 max-pain magnet. Solid 41% profit margin (9% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.
Clinical research company IQVIA (NYSE: IQV) reported Q3 2026 results topping the market’s revenue expectations, with sales up 8% year on year to $4.43 billion. The company expects the full year’s revenue to be around $17
IQVIA delivered an 8% year-over-year revenue increase in Q3, with results that outpaced Wall Street expectations and prompted a positive market reaction. Management attributed this performance to accelerated growth in bo
TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $288 to $307.
Our three best-performing stocks this quarter were Meta, IQVIA and Shell. Read more here.
JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $295 to $325.
WM's Q3 earnings miss estimates as higher fuel and risk management costs weigh on margins, while revenues beat expectations.
Truist Securities analyst Jailendra Singh maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $329 to $346.
For questions about this article or underlying research, email help@trefis.com.
Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $290 to $310.
IQVIA Holdings slipped about 0.8% in the first trading session after its Q3 2026 release, a muted move for a stock that has quietly added roughly 9.7% over the past three months. The reaction looks modest next to what th
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on IQV today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for IQV. Explore sector supply chains on /butterfly.
Why IQV Stock slipped -1.43% Today — RQD Quant Desk Flash. Solid 41% profit margin (9% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.